Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Metabolite Identification, Reaction Phenotyping, and Retrospective Drug-Drug Interaction Predictions of 17-Deacetylnorgestimate, the Active Component of the Oral Contraceptive Norgestimate

Deepak Ahire, Sarmistha Sinha, Barry Brock, Ramaswamy Iyer, Sandhya Mandlekar and Murali Subramanian
Drug Metabolism and Disposition June 2017, 45 (6) 676-685; DOI: https://doi.org/10.1124/dmd.116.073940
Deepak Ahire
Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center, Syngene International Ltd., Bangalore, India (D.A., S.S., M.S.); Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pennington, New Jersy (B.B., R.I.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb India Ltd., Bangalore, India: (S.M.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarmistha Sinha
Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center, Syngene International Ltd., Bangalore, India (D.A., S.S., M.S.); Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pennington, New Jersy (B.B., R.I.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb India Ltd., Bangalore, India: (S.M.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barry Brock
Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center, Syngene International Ltd., Bangalore, India (D.A., S.S., M.S.); Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pennington, New Jersy (B.B., R.I.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb India Ltd., Bangalore, India: (S.M.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ramaswamy Iyer
Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center, Syngene International Ltd., Bangalore, India (D.A., S.S., M.S.); Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pennington, New Jersy (B.B., R.I.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb India Ltd., Bangalore, India: (S.M.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandhya Mandlekar
Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center, Syngene International Ltd., Bangalore, India (D.A., S.S., M.S.); Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pennington, New Jersy (B.B., R.I.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb India Ltd., Bangalore, India: (S.M.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Murali Subramanian
Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center, Syngene International Ltd., Bangalore, India (D.A., S.S., M.S.); Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pennington, New Jersy (B.B., R.I.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb India Ltd., Bangalore, India: (S.M.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 45 no. 6 676-685
DOI 
https://doi.org/10.1124/dmd.116.073940
PubMed 
28283499

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received October 17, 2016
  • Accepted March 6, 2017
  • Published online May 12, 2017.

Article Versions

  • Earlier version (March 10, 2017 - 10:54).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Deepak Ahire1,
  2. Sarmistha Sinha1,
  3. Barry Brock,
  4. Ramaswamy Iyer,
  5. Sandhya Mandlekar, and
  6. Murali Subramanian
  1. Pharmaceutical Candidate Optimization, Biocon Bristol-Myers Squibb R&D Center, Syngene International Ltd., Bangalore, India (D.A., S.S., M.S.); Pharmaceutical Candidate Optimization, Bristol-Myers Squibb, Pennington, New Jersy (B.B., R.I.); and Pharmaceutical Candidate Optimization, Bristol-Myers Squibb India Ltd., Bangalore, India: (S.M.)
  1. Address correspondence to:
    Murali Subramanian, Biocon Bristol-Myers Squibb Research and Development Center, Syngene International Ltd., Biocon Park Plot 2 & 3 Bommasandra IV Phase Bangalore-560 099, India. E-mail: murali.subramanian{at}syngeneintl.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: March 2017 to April 2022

AbstractFullPdf
Mar 201764521214
Apr 2017433171
May 20173918067
Jun 20172041521
Jul 201778815
Aug 2017641720
Sep 2017471228
Oct 2017591020
Nov 201764622
Dec 20175999
Jan 201888620
Feb 2018541115
Mar 2018291719
Apr 201835920
May 2018132114
Jun 2018102635
Jul 201872439
Aug 201844030
Sep 201882128
Oct 201873854
Nov 201893339
Dec 201812022
Jan 201952225
Feb 201962227
Mar 2019134465
Apr 201984869
May 201913152
Jun 201923359
Jul 201933526
Aug 201922832
Sep 201913050
Oct 201924355
Nov 201982135
Dec 2019113524
Jan 202032738
Feb 202052768
Mar 202043532
Apr 202074550
May 202091845
Jun 2020111122
Jul 202071633
Aug 202061538
Sep 202071744
Oct 202051544
Nov 202051734
Dec 202061730
Jan 202182258
Feb 2021111534
Mar 202193420
Apr 20219109
May 202111919
Jun 20214178
Jul 202172318
Aug 202192536
Sep 202182039
Oct 202131649
Nov 202141739
Dec 202163514
Jan 202221819
Feb 202293420
Mar 2022293335
Apr 202233234

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 45 (6)
Drug Metabolism and Disposition
Vol. 45, Issue 6
1 Jun 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Metabolite Identification, Reaction Phenotyping, and Retrospective Drug-Drug Interaction Predictions of 17-Deacetylnorgestimate, the Active Component of the Oral Contraceptive Norgestimate
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Predicting 17-Deacetylnorgestimate Drug-Drug Interactions

Deepak Ahire, Sarmistha Sinha, Barry Brock, Ramaswamy Iyer, Sandhya Mandlekar and Murali Subramanian
Drug Metabolism and Disposition June 1, 2017, 45 (6) 676-685; DOI: https://doi.org/10.1124/dmd.116.073940

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Predicting 17-Deacetylnorgestimate Drug-Drug Interactions

Deepak Ahire, Sarmistha Sinha, Barry Brock, Ramaswamy Iyer, Sandhya Mandlekar and Murali Subramanian
Drug Metabolism and Disposition June 1, 2017, 45 (6) 676-685; DOI: https://doi.org/10.1124/dmd.116.073940
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Determination of Acyl-, O-, and N-Glucuronide
  • TMDD Affects PK of IL-10 Fc-fusion Proteins
  • Uptake as the RDS in Pevonedistat Hepatic Clearance
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics